APO Research
Talk to an analyst

APO RESEARCH · REPORT

Self Injection Device

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.

An auto-injector is a medical device designed to deliver a dose of a particular drug.

Selected research

Market Outlook & Growth Opportunities

Global Self Injection Device Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchSelf Injection Device Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Self Injection Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Self Injection Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Self Injection Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Self Injection Device Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.

An auto-injector is a medical device designed to deliver a dose of a particular drug.

Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.

This report provides an overview of the global Self Injection Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Self Injection Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Self Injection Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Self Injection Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Self Injection Device Segment by Company

Novo Nordisk

Mylan

Pfizer

Sanofi

BD

Eli Lilly

Gerresheimer

Dongbao

Ypsomed

Owen Mumford

Antares Pharma

Haselmeier

Self Injection Device Segment by Type

Reusable Self Injection Device

Disposable Self Injection Device

Self Injection Device Segment by Application

Insulin Injection

Epinephrine Injection

Others

Self Injection Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Self Injection Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Self Injection Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Self Injection Device significant trends, drivers, influence factors in global and regions.

6. To analyze Self Injection Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self Injection Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Self Injection Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self Injection Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Self Injection Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Self Injection Device industry.

Chapter 3: Detailed analysis of Self Injection Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Self Injection Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Self Injection Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Self Injection Device Industry Trends Table 2. Self Injection Device Industry Drivers Table 3. Self Injection Device Industry Opportunities and Challenges Table 4. Self Injection Device Industry Restraints Table 5. Global Self Injection Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Self Injection Device Revenue Share by Company (2021-2026) Table 7. Global Self Injection Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Self Injection Device Sales Volume Share by Company (2021-2026) Table 9. Global Self Injection Device Average Price (USD/Units) of Company (2021-2026) Table 10. Global Self Injection Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Self Injection Device Key Company Manufacturing Base & Headquarters Table 12. Global Self Injection Device Company, Product Type & Application Table 13. Global Self Injection Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Self Injection Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Reusable Self Injection Device Table 18. Significant Companies of Disposable Self Injection Device Table 19. Global Self Injection Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Self Injection Device Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Self Injection Device Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Self Injection Device Sales Volume Share by Type (2021-2026) Table 23. Global Self Injection Device Sales Volume Share by Type (2027-2032) Table 24. Global Self Injection Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Self Injection Device Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Self Injection Device Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Self Injection Device Sales Value Share by Type (2021-2026) Table 28. Global Self Injection Device Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Insulin Injection Table 30. Significant Companies of Epinephrine Injection Table 31. Significant Companies of Others Table 32. Global Self Injection Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Self Injection Device Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Self Injection Device Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Self Injection Device Sales Volume Share by Application (2021-2026) Table 36. Global Self Injection Device Sales Volume Share by Application (2027-2032) Table 37. Global Self Injection Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Self Injection Device Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Self Injection Device Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Self Injection Device Sales Value Share by Application (2021-2026) Table 41. Global Self Injection Device Sales Value Share by Application (2027-2032) Table 42. Global Self Injection Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Self Injection Device Sales by Region (2021-2026) & (K Units) Table 44. Global Self Injection Device Sales Market Share by Region (2021-2026) Table 45. Global Self Injection Device Sales by Region (2027-2032) & (K Units) Table 46. Global Self Injection Device Sales Market Share by Region (2027-2032) Table 47. Global Self Injection Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Self Injection Device Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Self Injection Device Sales Value Share by Region (2021-2026) Table 50. Global Self Injection Device Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Self Injection Device Sales Value Share by Region (2027-2032) Table 52. Global Self Injection Device Market Average Price (USD/Units) by Region (2021-2026) Table 53. Global Self Injection Device Market Average Price (USD/Units) by Region (2027-2032) Table 54. Global Self Injection Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Self Injection Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Self Injection Device Sales by Country (2021-2026) & (K Units) Table 57. Global Self Injection Device Sales Market Share by Country (2021-2026) Table 58. Global Self Injection Device Sales by Country (2027-2032) & (K Units) Table 59. Global Self Injection Device Sales Market Share by Country (2027-2032) Table 60. Global Self Injection Device Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Self Injection Device Sales Value Market Share by Country (2021-2026) Table 62. Global Self Injection Device Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Self Injection Device Sales Value Market Share by Country (2027-2032) Table 64. Novo Nordisk Company Information Table 65. Novo Nordisk Business Overview Table 66. Novo Nordisk Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 67. Novo Nordisk Self Injection Device Product Portfolio Table 68. Novo Nordisk Recent Development Table 69. Mylan Company Information Table 70. Mylan Business Overview Table 71. Mylan Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 72. Mylan Self Injection Device Product Portfolio Table 73. Mylan Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 77. Pfizer Self Injection Device Product Portfolio Table 78. Pfizer Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 82. Sanofi Self Injection Device Product Portfolio Table 83. Sanofi Recent Development Table 84. BD Company Information Table 85. BD Business Overview Table 86. BD Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 87. BD Self Injection Device Product Portfolio Table 88. BD Recent Development Table 89. Eli Lilly Company Information Table 90. Eli Lilly Business Overview Table 91. Eli Lilly Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 92. Eli Lilly Self Injection Device Product Portfolio Table 93. Eli Lilly Recent Development Table 94. Gerresheimer Company Information Table 95. Gerresheimer Business Overview Table 96. Gerresheimer Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 97. Gerresheimer Self Injection Device Product Portfolio Table 98. Gerresheimer Recent Development Table 99. Dongbao Company Information Table 100. Dongbao Business Overview Table 101. Dongbao Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 102. Dongbao Self Injection Device Product Portfolio Table 103. Dongbao Recent Development Table 104. Ypsomed Company Information Table 105. Ypsomed Business Overview Table 106. Ypsomed Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 107. Ypsomed Self Injection Device Product Portfolio Table 108. Ypsomed Recent Development Table 109. Owen Mumford Company Information Table 110. Owen Mumford Business Overview Table 111. Owen Mumford Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 112. Owen Mumford Self Injection Device Product Portfolio Table 113. Owen Mumford Recent Development Table 114. Antares Pharma Company Information Table 115. Antares Pharma Business Overview Table 116. Antares Pharma Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 117. Antares Pharma Self Injection Device Product Portfolio Table 118. Antares Pharma Recent Development Table 119. Haselmeier Company Information Table 120. Haselmeier Business Overview Table 121. Haselmeier Self Injection Device Sales (K Units), Value (US$ Million), Price (USD/Units) and Gross Margin (2021-2026) Table 122. Haselmeier Self Injection Device Product Portfolio Table 123. Haselmeier Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Self Injection Device Distributors List Table 127. Self Injection Device Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Self Injection Device Product Image Figure 2. Global Self Injection Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Self Injection Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Self Injection Device Sales (2021-2032) & (K Units) Figure 5. Global Self Injection Device Sales Average Price (USD/Units) & (2021-2032) Figure 6. Global Self Injection Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Reusable Self Injection Device Image Figure 10. Disposable Self Injection Device Image Figure 11. Global Self Injection Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Self Injection Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Self Injection Device Sales Volume Share by Type (2021-2032) Figure 14. Global Self Injection Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Self Injection Device Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Self Injection Device Sales Value Share by Type (2021-2032) Figure 17. Insulin Injection Image Figure 18. Epinephrine Injection Image Figure 19. Others Image Figure 20. Global Self Injection Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Self Injection Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Self Injection Device Sales Volume Share by Application (2021-2032) Figure 23. Global Self Injection Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Self Injection Device Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Self Injection Device Sales Value Share by Application (2021-2032) Figure 26. Global Self Injection Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Self Injection Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Self Injection Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Self Injection Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Self Injection Device Sales Value (2021-2032) & (US$ Million) Figure 31. North America Self Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Self Injection Device Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Self Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Self Injection Device Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Self Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Self Injection Device Sales Value (2021-2032) & (US$ Million) Figure 37. South America Self Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Self Injection Device Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Self Injection Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Self Injection Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Self Injection Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Self Injection Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Self Injection Device Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Self Injection Device Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Reusable Self Injection Device
  • Disposable Self Injection Device
Applications
  • Insulin Injection
  • Epinephrine Injection
  • Others
Companies covered
  • Novo Nordisk
  • Mylan
  • Pfizer
  • Sanofi
  • BD
  • Eli Lilly
  • Gerresheimer
  • Dongbao
  • Ypsomed
  • Owen Mumford
  • Antares Pharma
  • Haselmeier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Self Injection Device Sales Value (2021-2032)
  4. 1.2.2 Global Self Injection Device Sales Volume (2021-2032)
  5. 1.2.3 Global Self Injection Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Self Injection Device Market Dynamics
  1. 2.1 Self Injection Device Industry Trends
  2. 2.2 Self Injection Device Industry Drivers
  3. 2.3 Self Injection Device Industry Opportunities and Challenges
  4. 2.4 Self Injection Device Industry Restraints
3 Self Injection Device Market by Company
  1. 3.1 Global Self Injection Device Company Revenue Ranking in 2025
  2. 3.2 Global Self Injection Device Revenue by Company (2021-2026)
  3. 3.3 Global Self Injection Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Self Injection Device Average Price by Company (2021-2026)
  5. 3.5 Global Self Injection Device Company Ranking (2024-2026)
  6. 3.6 Global Self Injection Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Self Injection Device Company Product Type and Application
  8. 3.8 Global Self Injection Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Self Injection Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Self Injection Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Self Injection Device Market by Type
  1. 4.1 Self Injection Device Type Introduction
  2. 4.1.1 Reusable Self Injection Device
  3. 4.1.2 Disposable Self Injection Device
  4. 4.2 Global Self Injection Device Sales Volume by Type
  5. 4.2.1 Global Self Injection Device Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Self Injection Device Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Self Injection Device Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Self Injection Device Sales Value by Type
  9. 4.3.1 Global Self Injection Device Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Self Injection Device Sales Value by Type (2021-2032)
  11. 4.3.3 Global Self Injection Device Sales Value Share by Type (2021-2032)
5 Self Injection Device Market by Application
  1. 5.1 Self Injection Device Application Introduction
  2. 5.1.1 Insulin Injection
  3. 5.1.2 Epinephrine Injection
  4. 5.1.3 Others
  5. 5.2 Global Self Injection Device Sales Volume by Application
  6. 5.2.1 Global Self Injection Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Self Injection Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Self Injection Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Self Injection Device Sales Value by Application
  10. 5.3.1 Global Self Injection Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Self Injection Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Self Injection Device Sales Value Share by Application (2021-2032)
6 Self Injection Device Regional Sales and Value Analysis
  1. 6.1 Global Self Injection Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Self Injection Device Sales by Region (2021-2032)
  3. 6.2.1 Global Self Injection Device Sales by Region: 2021-2026
  4. 6.2.2 Global Self Injection Device Sales by Region (2027-2032)
  5. 6.3 Global Self Injection Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Self Injection Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Self Injection Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Self Injection Device Sales Value by Region (2027-2032)
  9. 6.5 Global Self Injection Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Self Injection Device Sales Value (2021-2032)
  12. 6.6.2 North America Self Injection Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Self Injection Device Sales Value (2021-2032)
  15. 6.7.2 Europe Self Injection Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Self Injection Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Self Injection Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Self Injection Device Sales Value (2021-2032)
  21. 6.9.2 South America Self Injection Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Self Injection Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Self Injection Device Sales Value Share by Country, 2025 VS 2032
7 Self Injection Device Country-level Sales and Value Analysis
  1. 7.1 Global Self Injection Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Self Injection Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Self Injection Device Sales by Country (2021-2032)
  4. 7.3.1 Global Self Injection Device Sales by Country (2021-2026)
  5. 7.3.2 Global Self Injection Device Sales by Country (2027-2032)
  6. 7.4 Global Self Injection Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Self Injection Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Self Injection Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Self Injection Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Self Injection Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Self Injection Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Self Injection Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Self Injection Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Self Injection Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Self Injection Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Self Injection Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Self Injection Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Self Injection Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Self Injection Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Self Injection Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Self Injection Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Self Injection Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Self Injection Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Self Injection Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Self Injection Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Self Injection Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Self Injection Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Self Injection Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Self Injection Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Self Injection Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Self Injection Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Self Injection Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Self Injection Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Self Injection Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Self Injection Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Self Injection Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Self Injection Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Self Injection Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Self Injection Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Self Injection Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Self Injection Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Self Injection Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Self Injection Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Self Injection Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Self Injection Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Self Injection Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Self Injection Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Self Injection Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Self Injection Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Self Injection Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Self Injection Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Self Injection Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Self Injection Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Self Injection Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Self Injection Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Self Injection Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Self Injection Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Self Injection Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Self Injection Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Self Injection Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Self Injection Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Self Injection Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Self Injection Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Self Injection Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Self Injection Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Self Injection Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Self Injection Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Self Injection Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Self Injection Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Self Injection Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Self Injection Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Self Injection Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Self Injection Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Self Injection Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Self Injection Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Self Injection Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Self Injection Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Self Injection Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Self Injection Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Self Injection Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Self Injection Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Self Injection Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Self Injection Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Self Injection Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Self Injection Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Self Injection Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Self Injection Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Self Injection Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Self Injection Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Self Injection Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Self Injection Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Self Injection Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Self Injection Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Self Injection Device Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Self Injection Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Self Injection Device Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Self Injection Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Self Injection Device Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Self Injection Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Self Injection Device Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 BD
  26. 8.5.1 BD Company Information
  27. 8.5.2 BD Business Overview
  28. 8.5.3 BD Self Injection Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BD Self Injection Device Product Portfolio
  30. 8.5.5 BD Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Self Injection Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Self Injection Device Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Gerresheimer
  38. 8.7.1 Gerresheimer Company Information
  39. 8.7.2 Gerresheimer Business Overview
  40. 8.7.3 Gerresheimer Self Injection Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Gerresheimer Self Injection Device Product Portfolio
  42. 8.7.5 Gerresheimer Recent Developments
  43. 8.8 Dongbao
  44. 8.8.1 Dongbao Company Information
  45. 8.8.2 Dongbao Business Overview
  46. 8.8.3 Dongbao Self Injection Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Dongbao Self Injection Device Product Portfolio
  48. 8.8.5 Dongbao Recent Developments
  49. 8.9 Ypsomed
  50. 8.9.1 Ypsomed Company Information
  51. 8.9.2 Ypsomed Business Overview
  52. 8.9.3 Ypsomed Self Injection Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ypsomed Self Injection Device Product Portfolio
  54. 8.9.5 Ypsomed Recent Developments
  55. 8.10 Owen Mumford
  56. 8.10.1 Owen Mumford Company Information
  57. 8.10.2 Owen Mumford Business Overview
  58. 8.10.3 Owen Mumford Self Injection Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Self Injection Device Product Portfolio
  60. 8.10.5 Owen Mumford Recent Developments
  61. 8.11 Antares Pharma
  62. 8.11.1 Antares Pharma Company Information
  63. 8.11.2 Antares Pharma Business Overview
  64. 8.11.3 Antares Pharma Self Injection Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Antares Pharma Self Injection Device Product Portfolio
  66. 8.11.5 Antares Pharma Recent Developments
  67. 8.12 Haselmeier
  68. 8.12.1 Haselmeier Company Information
  69. 8.12.2 Haselmeier Business Overview
  70. 8.12.3 Haselmeier Self Injection Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Haselmeier Self Injection Device Product Portfolio
  72. 8.12.5 Haselmeier Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Self Injection Device Value Chain Analysis
  2. 9.1.1 Self Injection Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Self Injection Device Sales Mode & Process
  6. 9.2 Self Injection Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Self Injection Device Distributors
  9. 9.2.3 Self Injection Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst